Ollivier Legrand
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Phase 1 clinical trial of S64315, an intravenous MCL1 inhibitor, in patients with myeloid malignancies.
Journal: Leukemia & lymphoma
Published: July 26, 2026
Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.
Journal: Leukemia
Published: April 14, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2026
A specific bone marrow cytokine pattern in de novo acute myeloid leukemia.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 14, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study.
Journal: Clinical hematology international
Published: October 21, 2024
Dramatic ruxolitinib efficacy in chronic enteropathy associated with SLCO2A1 gene (CEAS).
Journal: Journal of digestive diseases
Published: June 09, 2024
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact.
Journal: Clinical hematology international
Published: September 08, 2023
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Journal: Bone marrow transplantation
Published: May 06, 2023
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases.
Journal: Bone marrow transplantation
Published: September 29, 2022
Last Updated: 09/26/2026